A Self-Assembled Affibody-Drug Conjugate Nanoagent for EGFR-Targeted Synergistic Codelivery of Exatecan and an MDM2 Inhibitory Peptide.
- DOI
- 10.1021/acs.molpharmaceut.6c00580
- Published
- 2026 Oct 5
- Container
- Molecular pharmaceutics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.molpharmaceut.6c00580,
title = {A Self-Assembled Affibody-Drug Conjugate Nanoagent for EGFR-Targeted Synergistic Codelivery of Exatecan and an MDM2 Inhibitory Peptide.},
author = {Zhao M and Gao W and Xia X and Xia XX and Qian ZG},
year = {2026},
journal = {Molecular pharmaceutics},
doi = {10.1021/acs.molpharmaceut.6c00580},
url = {https://doi.org/10.1021/acs.molpharmaceut.6c00580}
}RIS
TY - JOUR TI - A Self-Assembled Affibody-Drug Conjugate Nanoagent for EGFR-Targeted Synergistic Codelivery of Exatecan and an MDM2 Inhibitory Peptide. AU - Zhao M AU - Gao W AU - Xia X AU - Xia XX AU - Qian ZG PY - 2026 JO - Molecular pharmaceutics DO - 10.1021/acs.molpharmaceut.6c00580 UR - https://doi.org/10.1021/acs.molpharmaceut.6c00580 ER -
APA
M, Z., W, G., X, X., XX, X., & ZG, Q. (2026). A Self-Assembled Affibody-Drug Conjugate Nanoagent for EGFR-Targeted Synergistic Codelivery of Exatecan and an MDM2 Inhibitory Peptide.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00580
Source records
- pubmed · retrieved 2026-11-10T12:32:23.254Z
- europe-pmc · retrieved 2026-11-10T12:32:23.261Z